<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00910208</url>
  </required_header>
  <id_info>
    <org_study_id>2008-448</org_study_id>
    <secondary_id>1R21NR010929-01</secondary_id>
    <nct_id>NCT00910208</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy of Patient Controlled Analgesia in the Emergency Department</brief_title>
  <official_title>Safety and Efficacy of Patient Controlled Analgesia in the Emergency Department</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Albert Einstein College of Medicine, Inc.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute of Nursing Research (NINR)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Jacobi Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Albert Einstein College of Medicine, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aims of this study are to assess efficacy and safety of patient-controlled analgesia
      (PCA) when applied to the Emergency Department setting and to compare the efficacy and safety
      of two PCA dosing regimens.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The safety, efficacy, and dosing of PCA will be assessed in a randomized trial with three
      treatment arms:

        1. PCA with 1.0 mg morphine demand dosing every 6 minutes,

        2. PCA with 1.5 mg demand dosing every 6 minutes and

        3. a non-PCA comparison group.

      All patients will receive a loading dose of 0.1 mg/kg morphine. All patients can receive
      additional analgesics as needed, at the discretion of the provider.

      We hypothesize that morphine supplied via PCA will provide superior analgesia without a
      greater incidence of adverse events when compared to non-PCA pain management; and that PCA
      demand dosing of 1.5 mg will be superior to 1.0 mg without more adverse events.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2009</start_date>
  <completion_date type="Actual">June 2010</completion_date>
  <primary_completion_date type="Actual">June 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Short-term pain relief: Change in pain intensity from baseline to 30 minutes; Pain relief at 30 minutes</measure>
    <time_frame>30 minutes</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Long-term pain relief: Total analgesia provided over 2 hours; Pain relief at 2 hours</measure>
    <time_frame>2 hours</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of adverse events: Oxygen saturation &lt; 92%; respiratory rate &lt;10 breaths/min; systolic blood pressure &lt; 90 mm Hg)</measure>
    <time_frame>2 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Need for supplementary analgesia</measure>
    <time_frame>2 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">211</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>PCA 1 mg demand dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>0.1 mg/kg morphine loading dose followed by PCA with 1.0 mg morphine demand dosing every 6 minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PCA 1.5 mg demand dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>0.1 mg/kg morphine loading dose followed by PCA with 1.5 mg morphine demand dosing every 6 minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-PCA comparison group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>0.1 mg/kg morphine loading dose followed by additional analgesia supplemented as needed at the discretion of the treating physician, using usual procedures for monitoring and treating pain.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Patient-controlled analgesia</intervention_name>
    <description>Intravenous morphine delivered via Curlin painsmart PCA device</description>
    <arm_group_label>PCA 1 mg demand dose</arm_group_label>
    <arm_group_label>PCA 1.5 mg demand dose</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>morphine</intervention_name>
    <description>Intravenous morphine</description>
    <arm_group_label>PCA 1 mg demand dose</arm_group_label>
    <arm_group_label>PCA 1.5 mg demand dose</arm_group_label>
    <arm_group_label>Non-PCA comparison group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients presenting to the ED with a chief complaint of abdominal pain of less than or
             equal to 7 days duration

          -  Age 18 to 65 years

          -  Patient deemed by the ED attending physician to require IV opioid analgesia

        Exclusion Criteria:

          -  Current use of prescription or non-prescription opioids

          -  Long-term use of opioids, chronic pain syndrome

          -  Clinician suspicion of opioid dependence/abuse

          -  Clinical suspicion of intoxication

          -  Pregnancy or breast-feeding

          -  History of chronic obstructive pulmonary disease, history of sleep apnea, oxygen
             saturation &lt; 97%

          -  Systolic blood pressure &lt; 100 mm Hg

          -  Use of monoamine oxidase inhibitors, phenothiazines, or tricyclic antidepressants

          -  History of renal insufficiency/renal failure

          -  Prior allergic reaction to morphine

          -  Inability to provide informed consent

          -  Previous entry of patient into study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Adrienne J Birnbaum, MD, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Jacobi Medical Center, Albert Einstein College of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Polly E Bijur, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Albert Einstein College of Medicine, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Jacobi Medical Center</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10461</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 27, 2009</study_first_submitted>
  <study_first_submitted_qc>May 28, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 29, 2009</study_first_posted>
  <last_update_submitted>July 12, 2012</last_update_submitted>
  <last_update_submitted_qc>July 12, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 13, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pain</keyword>
  <keyword>Analgesia</keyword>
  <keyword>Analgesia, Patient-controlled</keyword>
  <keyword>Emergency Medicine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Emergencies</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

